Navigation Links
New Study: Pine Bark Extract Boosts Nitric Oxide (NO) Production
Date:10/17/2007

in response to neurotransmitter stimulation.

"Acetylcholine stimulates the cells of arteries to produce NO from L-arginine faster," Dr. Higashi said. "In turn, the NO causes the muscle surrounding arteries to relax, which results in an increase of blood vessel diameters. When subjects had taken Pycnogenol(R) the relaxation of arteries was increased by 42 percent as compared to the group taking placebo tablets."

According to Frank Schonlau, Ph.D, director of scientific communications for Horphag Research, worldwide distributors of Pycnogenol(R), "While more research is warranted, this is an encouraging breakthrough especially to athletes as Pycnogenol(R) seems to allow people to move faster when exercising by satisfying the enhanced muscle oxygen demand and increasing the blood flow to active muscles. When people are performing heavy physical activity, nerves release neurotransmitter acetylcholine to arteries supplying muscles, which makes them expand, a process that requires enhanced production of NO."

A multitude of studies about Pycnogenol(R) and sports nutrition have been conducted. Most recently, a year ago, Pycnogenol(R) was demonstrated to improve blood circulation and support a lasting aerobic muscle activity during any kind of activity and enhance sports endurance by alleviating cramping and muscular pain in athletes. In short, Pycnogenol(R) is effective for enhancing and prolonging muscle performance during sport, supports muscle adaptation to higher work-load and allows for faster physical recovery.

About Pycnogenol(R)

Pycnogenol(R) is a natural plant extract originating from the bark of the maritime pine that grows along the coast of southwest France and is found to contain a unique combination of procyanidins, bioflavonoids and organic acids, which offer extensive natural health benefits. The extract has been widely studied for the past 35 years and has more than 220 published studies and review articles ensuring safety and
'/>"/>

SOURCE Natural Health Science Inc.
Copyright©2007 PR Newswire.
All rights reserved

3

GOOD

Page: 1 2 3

Related medicine technology :

1. Breaking Multi-Center Study: Masimo SET Pulse Oximetry Technology Shown to Significantly Lower Instances of Severe Retinopathy of Prematurity in Extremely Low Birth Weight Infants
2. Study: Identical Doses of BiDil Components Are Not Bioequivalent to the Fixed Dose Combination-BiDil-Used in A-HeFT
3. Inflazyme Announces Outcome of Review of Phase 2b Asthma Study: Potential Mitigating Factors Identified which Prevent Clear Interpretation of Results
4. HepaLifes PBS-1 Cells for Influenza Vaccine Production Prove Superior at International Conference
5. Research Documents Scalable Production, Survival Following Engraftment and Positive Impact on Cardiac Function in Infarcted Rats for Gerons Human Embryonic Stem Cell-Based Therapeutic for Heart Failure
6. Mymetics HIV Vaccine Demonstrates First-Ever Production of Neutralizing IgA Antibodies in Non-Human Primate Model
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/16/2009)... DATATRAK International, Inc. (OTCQX: DATA), a technology ... solutions for the clinical trials industry, today ... eClinical Software. This release advances the ... delivery and introduces two new mechanisms for ... Learning Center(TM) and the DATATRAK Learning Manager(TM). ...
(Date:12/16/2009)... Dec. 16 Hospira, Inc. (NYSE: ... delivery company, today announced that it will host a ... results and projections for 2010 on Thursday, Feb. 4, ... will release its fourth-quarter and full-year 2009 results earlier ... the conference call. ,, A live webcast of the ...
(Date:12/16/2009)... 16 EuroPharma, Inc. signs exclusive ... use of super absorbency BCM-95® curcumin and ... The exclusive distribution territory for these ... store channel and professional channel, which includes ... BCM-95® is a highly absorbable curcumin. ...
Breaking Medicine Technology:DATATRAK's eClinical(TM) 9.0 Software Release furthers Vision of DATATRAK ONE(TM) 2DATATRAK's eClinical(TM) 9.0 Software Release furthers Vision of DATATRAK ONE(TM) 3DATATRAK's eClinical(TM) 9.0 Software Release furthers Vision of DATATRAK ONE(TM) 4EuroPharma Exclusive Distributor of BCM-95 and BosPure 2EuroPharma Exclusive Distributor of BCM-95 and BosPure 3Researchers prolong the plasma half life of biopharmaceutical proteins 14192 1Researchers prolong the plasma half life of biopharmaceutical proteins 14192 2Boston Scientific PROMUS 28R 29 and First Generation TAXUS 28R 29 Express 28R 29 Stents Continue Excellent Performance in SPIRIT III Trial 57889 1Boston Scientific PROMUS 28R 29 and First Generation TAXUS 28R 29 Express 28R 29 Stents Continue Excellent Performance in SPIRIT III Trial 57889 2Boston Scientific PROMUS 28R 29 and First Generation TAXUS 28R 29 Express 28R 29 Stents Continue Excellent Performance in SPIRIT III Trial 57889 3Boston Scientific PROMUS 28R 29 and First Generation TAXUS 28R 29 Express 28R 29 Stents Continue Excellent Performance in SPIRIT III Trial 57889 4KATE AND CASSIE CARE 21 This Harvest Season Charity Reaps the Benefits of Kate 26 Cassie wines 57888 1KATE AND CASSIE CARE 21 This Harvest Season Charity Reaps the Benefits of Kate 26 Cassie wines 57888 2
... Phase 2 Colorectal and Prostate Trials -- Company to ... Experts - SOUTH SAN FRANCISCO, Calif., May 4 ... announced that the Company will present new data from ... Company,s lead product candidate, at poster sessions during the ...
... Submits sNDA for NEXIUM Capsules for Risk Reduction of ... 4 AstraZeneca (NYSE: AZN ) today ... to the U.S. Food and Drug Administration (FDA) seeking ... esomeprazole magnesium for the risk reduction of low dose ...
Other Medicine Technology:Poniard Pharmaceuticals to Present New Data from Phase 2 Clinical Trials of Picoplatin in Multiple Tumor Types at the 45th Annual Meeting of the American Society of Clinical Oncology 2Poniard Pharmaceuticals to Present New Data from Phase 2 Clinical Trials of Picoplatin in Multiple Tumor Types at the 45th Annual Meeting of the American Society of Clinical Oncology 3Poniard Pharmaceuticals to Present New Data from Phase 2 Clinical Trials of Picoplatin in Multiple Tumor Types at the 45th Annual Meeting of the American Society of Clinical Oncology 4AstraZeneca Submits NDA for Low Dose Aspirin/Esomeprazole Combination Product 2AstraZeneca Submits NDA for Low Dose Aspirin/Esomeprazole Combination Product 3AstraZeneca Submits NDA for Low Dose Aspirin/Esomeprazole Combination Product 4
(Date:12/16/2009)... of C3: Colorectal Cancer Coalition,s advocacy efforts, $15 million ... included in the final Fiscal Year 2010 Defense Appropriations ... research cancers, like colorectal cancer, that are not addressed ... programs run by the U.S. Army Medical Research and ... funding for this new cancer research program was included ...
(Date:12/16/2009)... is long-term goal, researchers say , , WEDNESDAY, Dec. ... to predict whether a patient will suffer a second ... "This is an important new tool because studies have ... after a first stroke are more likely to die ... General Hospital and Harvard Medical School, said in an ...
(Date:12/16/2009)... plays a role in reducing inflammation in the lungs ... variant that plays a role in inflammation seems to ... as adults who smoke. , Researchers also found that ... had a lower risk of developing chronic obstructive pulmonary ... smoking. , "The gene seems to be protective of ...
(Date:12/16/2009)... health and environmental concerns about the emerging nanotechnology industry, ... behavior of nanoparticles in municipal sewage treatment plants ... published in ACS, journal Environmental Science & Technology ... Ecology and Hydrology and colleagues note that experts predict ... less than 1/1000th the width of a human hair ...
(Date:12/16/2009)... commonly found in fatty fish and algae help ... by the American Psychological Association. The finding connects ... people with schizophrenia; bipolar, obsessive-compulsive, and attention-deficit hyperactivity ... nervous system. , The study, reported in ... evidence that fish is brain food. The key ...
Breaking Medicine News(10 mins):Health News:House Creates New Cancer Research Program 2Health News:House Creates New Cancer Research Program 3Health News:New Stroke Tool May Predict Early Recurrence 2Health News:Gene Variant Seems to Guard Against Asthma, COPD 2Health News:Gene Variant Seems to Guard Against Asthma, COPD 3Health News:Behavior modification could ease concerns about nanoparticles 2Health News:New study links DHA type of omega-3 to better nervous-system function 2
... retinopathy who were destined to go blind within five ... treatment with Avastin , a well-known cancer drug, according ... Archives of Ophthalmology. ,This is a major breakthrough ... therapy and commonly develop radiation retinopathy, said Paul T. ...
... where the potentially lethal H5N1 strain of bird flu was ... ,"All the turkeys on the farm have been ... in the area, around 1,000 birds in all," Czech veterinary ... completed today (Friday)," he added. ,The H5N1 strain of ...
... people in Vietnam in the first six months of the ... period last year, the health ministry said Friday. ... 15 percent rise to 19,144 new infections from the mosquito-borne ... delta. ,Malaysia and other Southeast Asian countries have ...
... have formed a new compound AN2690, that might help ... an enzyme crucial for the protein synthesis of fungal ... team of researchers including Dickon Alley and Stephen Cusack ... Biology Laboratory (EMBL) outstation in Grenoble, France. ,AN2690 ...
... an Anglo-American company has been allowed to store white ... by the US Food and Drug Administration. ... immune system that defend the body against both infectious ... take 480-millilitre of blood from interested healthy individuals and ...
... environmental group Friday welcomed the European Union (EU) Parliament's resolution ... the Indian government to do likewise. ,Toxics ... Wednesday. ,The group had called upon governments across ... United Nations Environment Programme (UNEP) in February. ...
Other Medicine News:Health News:Untreatable Eye Disease Improves With Avastin 2Health News:Researchers Devise New Compound to Treat Fungal Infections 2
... your data for future generations. Most gels can ... backing plate of our gel dryer, covering them ... over them to hold the cellophane flat. Tut's ... with an open area somewhat larger than the ...
... large sequencing gels or multiple smaller gels. Rugged design ... lasting durability and corrosion resistance., Large 40 x ... Drying Rate - large sequence gels can be dried ... of temperature and time , Cool-down ...
Inquire...
... and safely, the Hoefer GD 2000 uses a ... beneath the gel through a heavy aluminum platen. ... to 33 x 44 cm in as little ... even heat distribution and even vacuum distribution under ...
Medicine Products: